capitalcontrol

114 results found.

Top Stocks matching your search for "capital control"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

Both went up over 100% after the r/s and before the capital raise.

Dec, 22, 2022

$HTGM Oh yeah, don't forget that "if&quot... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 2, 2022

$HKD This stock has been an incredible opportunity... See more

Image with triangles

Divihomes is Now Live

Check out our new advanced search tool that can help you find the best home services in your area.

Search & Match

Instant Communication

Phone Image with DiviHomes website

Unbiased Reviews

100% Free

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 29, 2022

Amazing positive news from the TGTX 20221229 confe... See more

HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

Both went up over 100% after the r/s and before the capital raise.

Dec, 22, 2022

$HTGM Oh yeah, don't forget that "if" HTGM capital equipment and proprietary technology is sooo good.

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 2, 2022

$HKD This stock has been an incredible opportunity to downsize your capital for anyone who missed it!

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 29, 2022

Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.